Bárbara Angulo

980 total citations
17 papers, 723 citations indexed

About

Bárbara Angulo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Bárbara Angulo has authored 17 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Bárbara Angulo's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (6 papers) and HER2/EGFR in Cancer Research (4 papers). Bárbara Angulo is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (6 papers) and HER2/EGFR in Cancer Research (4 papers). Bárbara Angulo collaborates with scholars based in Spain, United States and United Kingdom. Bárbara Angulo's co-authors include Fernando López‐Ríos, Esther Conde, Montse Sánchez‐Céspedes, Ana Suárez‐Gauthier, Rebeca Martínez, Manuel Hidalgo, Moying Tang, Á. López Encuentra, Juan Torres‐Lanzas and Belén Rubio‐Viqueira and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Bárbara Angulo

17 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bárbara Angulo Spain 13 386 374 334 203 107 17 723
Shinsuke Hashida Japan 12 332 0.9× 382 1.0× 345 1.0× 225 1.1× 56 0.5× 30 719
Francesca Fenizia Italy 15 327 0.8× 208 0.6× 326 1.0× 401 2.0× 149 1.4× 25 622
Davide Torti Italy 12 304 0.8× 418 1.1× 116 0.3× 137 0.7× 77 0.7× 17 677
Leanne G. Ahronian United States 9 290 0.8× 198 0.5× 174 0.5× 226 1.1× 131 1.2× 18 524
Emily Burrows United States 6 636 1.6× 204 0.5× 350 1.0× 375 1.8× 83 0.8× 13 835
Zachery R. Reichert United States 13 392 1.0× 291 0.8× 389 1.2× 215 1.1× 36 0.3× 55 726
Jessica Young United States 12 270 0.7× 243 0.6× 159 0.5× 331 1.6× 85 0.8× 29 652
Katherine R. Singleton United States 11 209 0.5× 497 1.3× 190 0.6× 135 0.7× 50 0.5× 16 652
Sara D’Andrea Italy 13 350 0.9× 448 1.2× 95 0.3× 316 1.6× 75 0.7× 23 807
Matthew Dankner Canada 12 374 1.0× 390 1.0× 222 0.7× 119 0.6× 152 1.4× 29 747

Countries citing papers authored by Bárbara Angulo

Since Specialization
Citations

This map shows the geographic impact of Bárbara Angulo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bárbara Angulo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bárbara Angulo more than expected).

Fields of papers citing papers by Bárbara Angulo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bárbara Angulo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bárbara Angulo. The network helps show where Bárbara Angulo may publish in the future.

Co-authorship network of co-authors of Bárbara Angulo

This figure shows the co-authorship network connecting the top 25 collaborators of Bárbara Angulo. A scholar is included among the top collaborators of Bárbara Angulo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bárbara Angulo. Bárbara Angulo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Angulo, Bárbara, Roberto Pazo-Cid, Antonieta Salud, et al.. (2018). Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab. The Oncologist. 23(9). 1092–1102. 42 indexed citations
2.
Hernández, Susana, Esther Conde, Rebeca Martínez, et al.. (2017). P1.02-043 Multiplexed FISH (ALK/ROS1, RET, NTRK1) in Lung Adenocarcinomas: Novel Dual ALK/ROS1 Probe and Automated Scanning System. Journal of Thoracic Oncology. 12(1). S513–S514. 1 indexed citations
3.
Conde, Esther, Carolina Domínguez, Antonio Calles, et al.. (2017). Aligning digital CD8+ scoring and targeted next‐generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early‐stage squamous cell lung carcinoma. Histopathology. 72(2). 270–284. 15 indexed citations
4.
López‐Ríos, Fernando, Carolina Domínguez, Paula Jiménez Fonseca, et al.. (2016). PI3K upregulation as a negative predictive factor of survival in HER2 amplified gastric cancer treated with Trastuzumab.. Journal of Clinical Oncology. 34(15_suppl). e15567–e15567. 2 indexed citations
5.
Gómez-Martín, Carlos, Antonieta Salud, Paula Jiménez Fonseca, et al.. (2015). Detection of actionable oncogene drivers alterations in HER2-amplified gastric cancer by next generation sequencing.. Journal of Clinical Oncology. 33(3_suppl). 67–67. 1 indexed citations
6.
Angulo, Bárbara, Fernando López‐Ríos, & David González. (2014). A new generation of companion diagnostics: cobasBRAF, KRASandEGFRmutation detection tests. Expert Review of Molecular Diagnostics. 14(5). 517–524. 20 indexed citations
7.
López‐Ríos, Fernando, Bárbara Angulo, Rebeca Martínez, et al.. (2013). Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for Vemurafenib. PLoS ONE. 8(1). e53733–e53733. 38 indexed citations
8.
López‐Ríos, Fernando, Bárbara Angulo, Rebeca Martínez, et al.. (2013). Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer. Journal of Clinical Pathology. 66(5). 381–385. 43 indexed citations
9.
Angulo, Bárbara, Esther Conde, Ana Suárez‐Gauthier, et al.. (2012). A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry. PLoS ONE. 7(8). e43842–e43842. 86 indexed citations
10.
Conde, Esther, Bárbara Angulo, Elisa Izquierdo, et al.. (2012). The ALK translocation in advanced non‐small‐cell lung carcinomas: preapproval testing experience at a single cancer centre. Histopathology. 62(4). 609–616. 11 indexed citations
11.
12.
Conde, Esther, Bárbara Angulo, Óscar Toldos, et al.. (2010). The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung. PLoS ONE. 5(8). e12209–e12209. 50 indexed citations
13.
Angulo, Bárbara, Elena García-García, Rebeca Martínez, et al.. (2010). A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations. Journal of Molecular Diagnostics. 12(3). 292–299. 93 indexed citations
14.
Castillo, Sandra D., Bárbara Angulo, Ana Suárez‐Gauthier, et al.. (2010). Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer. The Journal of Pathology. 222(1). 89–98. 33 indexed citations
15.
Blanco, Raquel, Reika Iwakawa, Moying Tang, et al.. (2009). A gene-alteration profile of human lung cancer cell lines. Human Mutation. 30(8). 1199–1206. 102 indexed citations
16.
Conde, Esther, Bárbara Angulo, Moying Tang, et al.. (2006). Molecular Context of theEGFRMutations: Evidence for the Activation of mTOR/S6K Signaling. Clinical Cancer Research. 12(3). 710–717. 102 indexed citations
17.
Medina, Pedro P., Julián Carretero, Esteban Ballestar, et al.. (2005). Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells. Human Molecular Genetics. 14(7). 973–982. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinsuke Hashida Breakdown of academic impact, for papers by Francesca Fenizia Breakdown of academic impact, for papers by Davide Torti Breakdown of academic impact, for papers by Leanne G. Ahronian Breakdown of academic impact, for papers by Emily Burrows Breakdown of academic impact, for papers by Zachery R. Reichert Breakdown of academic impact, for papers by Jessica Young Breakdown of academic impact, for papers by Katherine R. Singleton Breakdown of academic impact, for papers by Sara D’Andrea Breakdown of academic impact, for papers by Matthew Dankner
Rankless by CCL
2026